AU7883298A - Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth factor receptor - Google Patents

Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth factor receptor

Info

Publication number
AU7883298A
AU7883298A AU78832/98A AU7883298A AU7883298A AU 7883298 A AU7883298 A AU 7883298A AU 78832/98 A AU78832/98 A AU 78832/98A AU 7883298 A AU7883298 A AU 7883298A AU 7883298 A AU7883298 A AU 7883298A
Authority
AU
Australia
Prior art keywords
growth factor
derived growth
platelet derived
cancers
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU78832/98A
Other versions
AU718272C (en
AU718272B2 (en
Inventor
Klaus Peter Hirth
Reiner Lammers
Elaina Mann
Donna Pruess Schwartz
Laura Kay Shawver
Axel Ullrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Sugen LLC
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Sugen LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/179,570 external-priority patent/US5700823A/en
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV, Sugen LLC filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority to AU78832/98A priority Critical patent/AU718272C/en
Priority claimed from AU78832/98A external-priority patent/AU718272C/en
Publication of AU7883298A publication Critical patent/AU7883298A/en
Application granted granted Critical
Publication of AU718272B2 publication Critical patent/AU718272B2/en
Publication of AU718272C publication Critical patent/AU718272C/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU78832/98A 1994-01-07 1998-08-06 Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth factor receptor Ceased AU718272C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU78832/98A AU718272C (en) 1994-01-07 1998-08-06 Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth factor receptor

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/179,570 US5700823A (en) 1994-01-07 1994-01-07 Treatment of platelet derived growth factor related disorders such as cancers
AU15633/95A AU690958B2 (en) 1994-01-07 1995-01-06 Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth factor receptor
AU78832/98A AU718272C (en) 1994-01-07 1998-08-06 Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth factor receptor
US179570 1998-10-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU15633/95A Division AU690958B2 (en) 1994-01-07 1995-01-06 Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth factor receptor

Publications (3)

Publication Number Publication Date
AU7883298A true AU7883298A (en) 1998-10-08
AU718272B2 AU718272B2 (en) 2000-04-13
AU718272C AU718272C (en) 2001-06-14

Family

ID=

Also Published As

Publication number Publication date
AU718272B2 (en) 2000-04-13

Similar Documents

Publication Publication Date Title
AU1520699A (en) Methods for treatment of disorders of cardiac contractility
AU5579996A (en) Decorative formation of tissue
AU5300996A (en) Use of angiogenesis suppressors for inhibiting hair growth
IL121170A0 (en) Compositions for the treatment of dermatological disorders
PL322584A1 (en) Inhibitors of proteinous kinase c
AU5750796A (en) System for the treatment of insomnia
AU5441096A (en) Analogs of growth hormone-releasing factor
AU698509B2 (en) Compositions for the treatment of rheumatoid-based arthritic diseases
IL138129A (en) Composition for therapy of estrogen-associated disorders
AU7256296A (en) Use of metallofluorocomplexes for dental compositions
AU4078997A (en) Cholinesterase inhibitors for treatment of parkinson's disease
AU4067697A (en) Therapeutic compositions for treatment of cancer
HUP9801532A3 (en) Use of benzimidazole derivatives for producing pharmaceutical compositions for inhibiting the growth of cancers
ZA98643B (en) Method for inhibiting the growth of cancers
AU2953997A (en) Production of apomictic seed
AU2396000A (en) Treatment of hyperproliferative disorders using casein kinase
AU2871195A (en) Methods for the synthesis of diketopiperazines
AU6683396A (en) Use of fluconazole for inhibiting the growth of cancers
AU6683496A (en) Use of griseofulvin for inhibiting the growth of cancers
AU3784999A (en) Methods for treatment of pain
AU2424895A (en) Substituted spirodienes for the treatment of inflammation
AU6858596A (en) Compounds for stimulating nerve growth
AU8156094A (en) Methods of inhibiting breast disorders
AU2821295A (en) Compositions and methods for the treatment of tumors
AU3918797A (en) Composition for the treatment of rice seeds

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
DA2 Applications for amendment section 104

Free format text: FT="THE" NATURE OF THE PROPOSED AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 20000704

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS WAS NOTIFIED IN THE OFFICIAL JOURNAL DATED 20000914